Once-weekly exenatide, the recently approved GLP-1 receptor agonist, may help improve treatment adherence and outcomes in patients with type 2 diabetes.
Amanda M. Stahnke, PharmD
Advertisement
Articles by Amanda M. Stahnke, PharmD
Advertisement
Latest Updated Articles
- New Once-Weekly Exenatide for Type 2 Diabetes
Published: July 14th 2012 | Updated:
Advertisement
Advertisement
Trending on Patient Care Online
1
The Menopause Society 2025 Annual Meeting: A Primary Care Preview
2
Investigational Two-Drug HIV Regimen Shows Minimal Impact on Weight and Lipids in Phase 3 Trials
3
Real-Time CGM Reduces Risk of Large Newborns in Gestational Diabetes: Daily Dose
4
Three GLP-1 Receptor Agonists Show Comparable Cardiorenal Protection in Large US Cohort with T2D
5
